NH and VT Settle with Cephalon

proviglBoth NH and VT Attorney Generals have made a settlement with pharmaceutical manufacturer Cephalon for the wakefulness drug, Provigil.

The settlement ends a multistate investigation into anticompetitive conduct by Cephalon and affiliated companies to protect the monopoly profits earned by delaying generic competition.

The $125 million dollars settlement with Cephalon is divided among 49 states.

Vermont consumers and the State of Vermont will receive a total of over $1.6 million and New Hampshire will receive $650,000.

The settlement is subject to court review, including providing consumers with notice and an opportunity to participate in, object to, or opt out of settlement.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s